Nicole Germino's Stock Ratings

Truist Securities Analyst

Nicole Germino is an analyst at Truist Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024

Overall Average Return

7.68%

Smart Score

51.6%

Overall Average Return Percentile

57th

Number of Ratings

17
Buy NowGet Alert
06/28/2024YMABBuy Now
Y-mAbs Therapeutics
$12.0873.84% → $21Initiates → BuyGet Alert
05/29/2024INSMBuy Now
Insmed
$67.001.49%$48 → $68MaintainsBuyGet Alert
05/16/2024INSMBuy Now
Insmed
$67.00-28.36%$48 → $48MaintainsBuyGet Alert
04/23/2024INSMBuy Now
Insmed
$67.00-28.36% → $48Initiates → BuyGet Alert
03/20/2024FUSNBuy Now
Fusion Pharmaceuticals
——$11 → $21DowngradeBuy → HoldGet Alert
03/19/2024FUSNBuy Now
Fusion Pharmaceuticals
——$11 → $21DowngradeBuy → HoldGet Alert
11/07/2023SGMOBuy Now
Sangamo Therapeutics
$0.38——DowngradeBuy → HoldGet Alert
10/04/2023PNTBuy Now
POINT Biopharma Global
——$13 → $12.5DowngradeBuy → HoldGet Alert
08/15/2023SGMOBuy Now
Sangamo Therapeutics
$0.381742.11%$8 → $7MaintainsBuyGet Alert
05/10/2023SGMOBuy Now
Sangamo Therapeutics
$0.382005.26%$16 → $8MaintainsBuyGet Alert
11/15/2022PNTBuy Now
POINT Biopharma Global
——$22 → $14MaintainsBuyGet Alert
10/24/2022ASMBBuy Now
Assembly Biosciences
$14.42-86.13%$132 → $24DowngradeBuy → HoldGet Alert
09/16/2022FUSNBuy Now
Fusion Pharmaceuticals
—— → $10Initiates → BuyGet Alert
09/16/2022PNTBuy Now
POINT Biopharma Global
—— → $22Initiates → BuyGet Alert
04/05/2022SGMOBuy Now
Sangamo Therapeutics
$0.384900%$23 → $19MaintainsBuyGet Alert
04/01/2022ASMBBuy Now
Assembly Biosciences
$14.42-16.78%$180 → $144MaintainsBuyGet Alert
10/19/2020ASMBBuy Now
Assembly Biosciences
$14.42281.41% → $660Initiates → BuyGet Alert